10 Indian stocks to watch: Ranbaxy, Cairn India, Sesa Sterlite, more

Written by Reuters | Updated: Jan 25 2014, 02:48am hrs
BSE SensexLarsen &Toubro (L&T) Finance December quarter net profit down 7 percent. Reuters
Reserve Bank of India (RBI) head calls inflation 'destructive disease': Report

India's ruling party chief seeks easing of gold curbs: Report

India not yet planning roll back of gold import curbs: Finance Ministry

US FDA bans more products from Indian drugmaker Ranbaxy

Cairn India says Dec-quarter net down 13.77 pct

Bharti Airtel could raise up to $2 bn from Africa towers sale: Sources

Sesa Sterlite says has not proposed merger of Hindustan Zinc with co

Reserve Bank of India (RBI) aligns non-banking finance co loan recast rules with banks

Larsen &Toubro (L&T) Finance December quarter net profit down 7 percent

Biocon forced to move clinical trials out of India

ABG Shipyard gets record Rs 106 bn lifeline - (Financial Express)

Fare war in the skies: Jet slashes rates in two-day sale

Novartis India says December quarter net profit down 47.48 pct

India's GATI says looking for a strategic investor in its cold chain business

Span Diagnostics sells India business to Japanese firm Arkray

Plans to sell quasi-sovereign bonds may be shelved


Reserve Bank of India (RBI) Deputy governor K.C. Chakrabarty is heading a panel discussion on gold and its status in India at IIM Bangalore.

India's weekly statistical supplement (WSS) data.


* Nifty futures on the Singapore Exchange down 0.53 percent, while the MSCI-Asia Pacific excluding Japan index falls 0.35 percent.

* Asian shares were off-colour on Friday, extending the previous day's weakness as disappointing Chinese manufacturing data raised concerns over the economy, and investors sought safety in gold and the yen.

* US stocks fell on Thursday, with the Dow Jones industrial average recording its third consecutive day of losses, as risky assets sold off in wake of disappointing manufacturing data in China.